fbpx
HomeArchives for InVivo Biosystems

InVivo Biosystems

[Press Release] InVivo Biosystems and Thaena Announce Novel Metabolite Research Platform With Compelling Longevity and Healthspan Implications and Outcomes

– Mikra patent focusing on novel cellular therapeutic targeting systemic fatigue
– Mikra partners with InVivo Biosystems for pre-clinical trials to strengthen patent application and generate further data confirming expression pathways for genes

Read More »

What does it mean to be a Physician Scientist?

Jordan Shavit is a professor of Pediatrics and Human Genetics, and the Henry and Mala Dorfman Family Professor at the University of Michigan. Dr. Shavit’s research interests are the genetics of hematologic and cardiovascular diseases, including hemophilia and bleeding disorders, as well as excessive clotting, such as myocardial infarction, stroke, and deep vein thrombosis. He …

What does it mean to be a Physician Scientist? Read More »

What are Knock-outs and Knock-ins?

Knock-out and Knock-in technologies enable researchers to modify genes in a chosen model system, and thus, can reveal a lot about how a gene functions. However, while these two methods may sound like complementary opposites, their purpose and design can actually have major differences. In this whitepaper we will discuss the available Knock-out and Knock-in methods, and how they differ, so that you can determine which is best-suited for your experiment.

Read More »

[Press Release] Lifeist Subsidiary Mikra Cellular Sciences to Launch First Product “CELLF” to Combat Brain Fog and Unlock Healthy Aging, Announces U.S. Patent Application and Pre-Clinical Study

– Mikra patent focusing on novel cellular therapeutic targeting systemic fatigue
– Mikra partners with InVivo Biosystems for pre-clinical trials to strengthen patent application and generate further data confirming expression pathways for genes

Read More »

Scroll to Top